Introduction
It has been shown convincingly that reperfusion therapy for acute myocardial infarction started within 6 h of symptom onset results in an important mortality reduction [1, 2] , but there is no certainty about the relationship between the ischaemic time and clinical outcome. Although there is clear evidence that very early treatment, especially within the first 'golden hour' results in a considerable mortality benefit [3, 4] , few studies have addressed the influence of time to treatment, including patients who are treated later than 6 h after the onset of symptoms. Most studies report on patients treated with thrombolytic therapy. In these patients it is not known whether reperfusion actually occurs, and if so, the time is uncertain. Therefore we compared patient characteristics and outcome of patients divided into three different groups according to time intervals between onset of symptoms and opening of the infarct-related vessel in a cohort of consecutive myocardial infarct patients treated with primary coronary angioplasty. coronary angioplasty at our institution, according to the protocol of the Zwolle Myocardial Infarction trial. Inclusion and exclusion criteria for this trial have previously been described [5] . Patients who presented more than 6 h after symptom onset were only included if there was evidence of continuing ischaemia, which was defined as the presence of persistent chest pain and ST segment elevation. Patients were transported to the catheterization laboratory immediately after the diagnosis was made and coronary angioplasty was performed using standard techniques. Ischaemic time was defined as the time from symptom onset until the first balloon inflation. Flow through the infarct-related vessel was scored according to the Thrombolysis in Myocardial Infarction (TIMI) classification [6] . Primary angioplasty was considered successful if TIMI 3 flow was present after the procedure. Collaterals to the infarct-related vessel were classified as proposed by Rentrop et al. [7] . Grade 0: no visible filling of any collateral channels, grade 1: filling by means of collateral channels of side branches of the vessel but without any dye reaching the epicardial segment of that vessel, grade 2: partial filling via collateral channels of the epicardial segment of the vessel, grade 3: complete filling of the epicardial vessel. Follow-up coronary angiography was planned for all patients, with the exception of those who underwent early coronary artery bypass surgery or who had an unsuccessful angioplasty.
The left ventricular ejection fraction was measured before discharge and at 6 months follow-up, by radionuclide ventriculography using the multiple gated equilibrium method, as has been previously described [8] . For patients in whom both an ejection fraction was measured before hospital discharge and at follow-up, the change of left ventricular function was defined as the difference between the two values ( EF).
Recurrent myocardial infarction was defined as the combination of chest pain, changes in the ST-T segment at rest, and a second increase in the creatine kinase level to more than twice the upper limit of normal, or an increase of more than 200 U per litre over the previous value if the level had not dropped below the upper limit of normal. Total mortality was assessed at 6 months follow-up.
Statistical analysis
Differences between group means were tested by analysis of variance. A chi-square method or the Fisher exact test, adapted to analyse trends, were used to test differences between proportions. The Fisher exact test was used if there was an expected cell value <5. Continuous baseline and outcome variables are given as means SD, with the exception of ischaemic time, which is reported by median and percentiles 25 and 75 as this variable has a 'non-Gaussian' distribution. Discrete variables are given as percentages. Differences were considered statistically significant if the two-sided P value was <0·05. The outcome measures were analysed irrespective of whether the angioplasty procedure was successful. A stepwise logistic regression procedure was used to determine independent predictors associated with mortality or left ventricular function. For this analysis, continuous variables were converted into binary variables, with the 75th percentile as the cut off point.
Results
The ischaemic time was recorded in 490 patients (98%). This was less than 3 h in 44% of patients, defined as the 'early' group. Thirty-eight percent of patients had an ischaemic time between 3 and 6 h, the 'intermediate' group and 18% of patients were treated between 6 and 24 h of symptom onset because of signs of continuing ischaemia. This latter group was classified as the 'late' group. Median time from onset of symptoms to the first balloon inflation was 2·4 h, 4·1 h and 9·0 h for the three groups, respectively. Baseline characteristics are described in Table 1 . There was a significant trend towards a higher percentage of female patients and patients with diabetes and a longer ischaemic time. The other baseline characteristics were comparable in the three groups. The success rate of the primary angioplasty procedure, however, was highest in patients treated within 3 h. Results of the left ventricular ejection fraction for both inhospital and at follow-up are described in Table 2 . These measurements were available pre-discharge in 418 (85%) patients and at follow-up in 376 (82% of surviving patients). In patients with unsuccessful angioplasty the ejection fraction was measured in 33 patients (65%) pre-discharge and in 28 (78% of patients alive) at 6 months follow-up.
Both pre-discharge and follow-up measurements (paired data) were available in 358 patients. Although there is a trend towards a lower ejection fraction with longer ischaemic time, this did not reach statistical significance. However, the change in left ventricular ejection fraction function between pre-discharge and 6 months follow-up was related to ischaemic time. Patients with an ischaemic time of less than 3 h showed an increase in ejection fraction of 1·6%. For patients with an ischaemic time between 3 and 6 h the ejection fraction increased 1·3%. In the patients who had their first balloon inflation after 6 h, the ejection fraction decreased by 1·9%. After exclusion of patients with an occluded infarct-related vessel at follow-up angiography, these values for EF were 1·5%, 1·4%, and 1·5% respectively. Clinical and angiographic outcome at follow-up is described in Table 3 . In patients for whom a follow-up angiogram was planned, this procedure was performed in 162/183 (89%) of the early, in 121/139 (87%) of the intermediate, and in 59/71 (83%) of the late-entry patients (P=0·27). No patient was lost to follow-up. Reinfarction, death and reocclusion of the infarct-related vessel at follow-up angiography were related to ischaemic time, with the best outcome for patients treated within 3 h, and the poorest outcome for patients treated after 6 h of symptom onset. The results of the multivariate analysis are shown in Table 4 . Ischaemic time was related to both 6-month mortality and change in ejection fraction independent of age, heart rate at presentation, gender or the presence of diabetes.
Discussion
Two previous studies of patients treated with primary coronary angioplasty for acute myocardial infarction suggested that the time delay to reperfusion, even after 6 h, did not affect outcome [9, 10] . However, this study shows that the time from symptom-onset to first balloon inflation is related to some baseline clinical characteristics, left ventricular functional recovery and clinical outcome.
Baseline characteristics
The difference in baseline characteristics between the three groups of patients is consistent with the findings from other studies [11, 12] , who found female gender and diabetes to be independent variables for increasing patient delay. Ottesen et al. [12] found that older age and pre-infarction angina were also predictors for a long patient delay. Although our data show a trend in this direction, this was not significant. None of the other baseline characteristics were related to ischaemic time. Previous infarction, previous bypass surgery or hypertension, which were found to be variables predictive of later time to presentation in the GUSTO trial [11] , were equally distributed amongst the three groups in our study. This inability to detect some of these differences may be related to the relative small number of patients in our study.
Success of primary angioplasty
Our data show that the likelihood of achieving TIMI 3 flow of the infarct-related coronary artery is dependent on ischaemic time. Previous studies in patients treated with primary angioplasty did not find such a relationship [9, 10] . However, from a pathophysiological perspective, it is understandable that flow to a region with extensive necrosis due to prolonged occlusion of the infarct-related artery, may become less often normal. In patients with a longer ischaemic time, a higher incidence of impaired flow in the infarct-related vessel after reperfusion has been found by intracoronary Doppler measurements in humans as well as in an animal model [13, 14] .
Left ventricular function
Left ventricular ejection fraction in patients treated after 6 h was not significantly lower compared to patients treated within 6 h, although there was a trend in this direction. There was a significant difference in the extent of recovery of left ventricular function during follow-up between the three groups. After adjustment for differences in baseline characteristics by multivariate analysis, it was shown that ischaemic time independently predicted left ventricular function recovery (Table 4) . This is consistent with the findings of Hasche et al. [15] , who found the same in patients treated with thrombolytic therapy. An explanation for this lack of recovery of left ventricular function for patients treated late might be related to more extensive necrosis with absence of viable myocardium in the infarct region in late-treated patients. Studies using myocardial contrast echocardiography show that left ventricular function in these patients benefits less from reperfusion therapy compared to patients who have evidence of continued viability [16, 17] . The lower success rate of the angioplasty procedure or the lower patency rate of patients treated late does not explain the lack of recovery of left ventricular function. After exclusion of patients with an unsuccessful procedure or an occluded infarct-related vessel at follow-up, CI=confidence interval; EF=difference in left ventricular ejection fraction pre-discharge and at 6 month follow-up (n=358).
the difference in extent of recovery of left ventricular function persisted (Table 2) .
Clinical and angiographic outcome
Early treated patients have a better clinical and angiographic outcome at follow-up, compared to patients treated later. There is a substantial difference in mortality at follow-up. The difference in mortality is related to the difference in success rate of the angioplasty procedure between the three groups of patients. After exclusion of failed procedures, there is no longer a significant difference in 6 month mortality between the groups (Table 3) . Although it was recently reported that diabetes is an independent predictor of mortality after myocardial infarction [18] , the difference in incidence in diabetes between the groups does not explain the difference in mortality. Multivariate analysis showed that ischaemic time is an independent predictor of 6 month mortality, after adjustment for the differences in baseline characteristics between the groups (Table 4) .
Patients treated after 6 h more often had reocclusion of the infarct related vessel. There is a wealth of information which shows that late patency of the infarct related vessel is a strong predictor of long-term clinical outcome [19] . However, this study reported on reocclusion rates and not patency rates, because follow-up angiography was performed in patients after a successful angioplasty procedure. If one assumes that the infarctrelated vessel of the patients who underwent an unsuccessful procedure remained occluded (TIMI <3), patency rates at follow-up can be estimated. This is described in Table 5 and shows a significantly lower patency with later time to reperfusion. A lower patency rate at follow-up angiography for later-treated patients is in accordance with a study performed by Simari et al. in 1986 , who showed that time to reperfusion was a determinant of early reocclusion after angioplasty for acute myocardial infarction [20] . This may also explain the increased incidence of reinfarction in late treated patients.
Limitations of the study
We described a relatively small number of patients who underwent late reperfusion therapy. Baseline characteristics between the three groups were not similar for all variables: this probably reflects a true difference between patients treated early or late. Therefore this study is not merely a reflection of the effect of difference in time to treatment on outcome. This is a post-hoc analysis of the influence of ischaemic time on outcome in a large data-set of consecutive myocardial infarct patients treated with primary angioplasty. So far, the only studies in which the effect of time to reperfusion can be evaluated separately from confounding variables are those studies which randomize between pre-hospital and in-hospital thrombolysis [21, 22] . Late entry patients were only treated with reperfusion therapy if there were signs of continuing ischaemia, i.e. chest pain and ST segment elevation. This may have introduced a selection bias. Inclusion of all late entry patients, irrespective of signs of viable myocardium, would probably have resulted in different findings in this group, as reperfusion therapy seems most beneficial in patients with evidence of continued viability [23] .
Conclusions
This study shows that in patients, undergoing primary coronary angioplasty for acute myocardial infarction, the time from symptom-onset to first balloon inflation is related to some baseline clinical characteristics, procedural success rate, left ventricular functional recovery and clinical outcome. In patients treated within 3 h or between 3 and 6 h there is an improvement of the left ventricular ejection fraction during follow-up. Patients treated after 6 h are more often female and have a higher incidence of diabetes and a poorer clinical outcome. *Assumption: infarct related vessel after non-successful angioplasty remains non-patent at follow-up.
